[ad_1]
New York, January 17, 2022 /PRNewswire/ — Pomerantz LLP announced that it has filed a lawsuit against Organogenesis Holdings Inc. (“Organogenesis” or the “Company”) (NASDAQ:Orgo) and some of its personnel.class action, filed at America Eastern District Court New York, and recorded under 21-cv-06845, represents a class consisting of all persons and entities other than defendants who are March 17, 2021 and October 11, 2021, including two dates (the “Class Action Period”), seeking to recover damages resulting from Defendant’s violations of the federal securities laws and to seek remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (Sections “Exchange Act”) and rules 10b-5 Promulgated accordingly, against the company and some of its senior officers.
The full story is available on Benzinga.com
[ad_2]
Source link
